Equities

Embla Medical hf

Embla Medical hf

Actions
  • Price (DKK)36.20
  • Today's Change0.20 / 0.56%
  • Shares traded199.00
  • 1 Year change+31.88%
  • Beta--
Data delayed at least 20 minutes, as of Nov 26 2024 09:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments737785
Total Receivables, Net133117107
Total Inventory136132104
Prepaid expenses181414
Other current assets, total168.868.35
Total current assets376349318
Property, plant & equipment, net186179182
Goodwill, net691680644
Intangibles, net666259
Long term investments251716
Note receivable - long term------
Other long term assets0.000.00--
Total assets1,3861,3251,247
LIABILITIES
Accounts payable312927
Accrued expenses745957
Notes payable/short-term debt000
Current portion long-term debt/capital leases438767
Other current liabilities, total486235
Total current liabilities196237186
Total long term debt424394381
Total debt468481448
Deferred income tax293029
Minority interest3.12(0.19)5.01
Other liabilities, total312924
Total liabilities684690625
SHAREHOLDERS EQUITY
Common stock4.784.784.80
Additional paid-in capital616171
Retained earnings (accumulated deficit)707646597
Treasury stock - common------
Unrealized gain (loss)(1.01)(1.03)0.11
Other equity, total(70)(76)(51)
Total equity702636622
Total liabilities & shareholders' equity1,3861,3251,247
Total common shares outstanding420420422
Treasury shares - common primary issue0.702.710.74
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.